Loading...
Rapid versus Standard Infliximab and Infliximab Biosimilar Infusions in Pediatric Inflammatory Bowel Disease (IBD): Comparison of Adverse Reactions
Authors
Advisor
Date
2024-12-09
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Poster/Presentation
Research Area
Jurisdiction
Collections
Other Titles
See at
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Advances in Inflammatory Bowel Diseases (AIBD). December 09, 2024.
Citations
Altmetric: